Mankind Fin

download Mankind Fin

of 12

Transcript of Mankind Fin

  • 8/3/2019 Mankind Fin

    1/12

    Presented by:

    Radhika Aeron- PM46

    Hitesh Bhadiyadara-PM47

    Mayur Mistry-PM61

  • 8/3/2019 Mankind Fin

    2/12

    INTRODUCTION

    Established by Mr R C Juneja in 1995 withcapital of 50 lakhs.

    Mission : To deliver medicines that enablepatients to live healthier , happier and moreactive lives.

    Vision: To be the no 1 pharma company in Indiaby 2015. To mark the presence in formar CIScountries , South East Asia ,Africa and LatinAmerica.

  • 8/3/2019 Mankind Fin

    3/12

    History

    1995- Inception of mankind.

    2002-Established its operation all over india.

    2005- Launched lifestar pharma

    2007 Future mankind.

    2008- 4th rank in india as per ORG ims.

    2010- Successfully launched in OTC and alsolaunched mankind in Sri Lanka.

  • 8/3/2019 Mankind Fin

    4/12

    Financial growth

    Highest growth for mankind (37.2%) in yr 2010.

    Rs 1200 crore (FY 2009-10) sales turnover.

    Market share of 1.5% of the Rs 47,000 crore of

    Indian Pharma market.

  • 8/3/2019 Mankind Fin

    5/12

    PRODUCTS

    PRESCRIPTIONPRODUCTS OTC PRODUCTS

    ANIMALHEALTHCARE

    1. Anti dandruff:Rusy guardlotion.

    2. Oral

    contraceptives:-UNWANTED 72

    3. Condoms-Manforce

    Diabetic products

    Ophthalmic

    Dermal products

    Orthopedic drugs

    Neurological Psychiatric

    In veterinaryproducts

    Antibacterials

    Nutritionals

    Reproductive

    Digestivecategories etc.

  • 8/3/2019 Mankind Fin

    6/12

    COMPANY DIVISION

    Ophthalmic

    and dermal

    products

    anti-bacterials

    Diabeticproducts

    Anti-biotics

    GIproductsanti-fungal

    Lifestyle

    segment

    OTCproducts

    condoms

    toothbrush

    Sanitarynapkins

    sweeteners

    Orthopedicdrugs along

    with GI

    and other

    speciality

    products

    Neurological and

    psychiatr

    ic

    products

  • 8/3/2019 Mankind Fin

    7/12

    SWOTStrength Weakness

    Largest field force.

    Good penetration in ruralmarket

    Low price drugs.

    Strong product portfoliocomprising prescription ,OTC& veterinary products

    Lack of research anddevelopment.

    Weak brand image amongcompetitors.

    Wrong perceptions amongdoctors regarding drug quality.

  • 8/3/2019 Mankind Fin

    8/12

    Opportunities Threats

    Indias large untapped rural

    market.

    globalization or expansion ofcompany.

    Oncology products

    Price game by other generic

    drugs.

    MNC with patented moleculesare the biggest threat.

    Take over of IndianCompanies by MNC

  • 8/3/2019 Mankind Fin

    9/12

    HR policies

    Follows Performance appraisal system i.e. basedon principles of MBO (Management ByObjective)

    Different policies for different sectors:1. In Our Management Capacity

    RESPECTING the human rights of our employees

    PROVIDING security

  • 8/3/2019 Mankind Fin

    10/12

    2. With Our Direct Business Partners

    INCORPORATING

    MONITORING

    EVALUATING

    3.In the Community SERVING

    ASSESSING

  • 8/3/2019 Mankind Fin

    11/12

    Training n development

    Aims at continuous up-gradation of knowledgeand skills of our employees

    Designed focusing on the employees profile,qualifications and level of knowledge required.

    Different programmes are:

    Class Room Training for Sales peopleRefresher Courses

    Management Development Programme

  • 8/3/2019 Mankind Fin

    12/12